1. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1223,
2000,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
2. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1223,
2000,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
3. |
Paediatric immunisation schedule updated for 2000 |
|
Inpharma Weekly,
Volume &NA;,
Issue 1223,
2000,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
4. |
Continuous infusion of ticarcillin/clavulanic acid less costly |
|
Inpharma Weekly,
Volume &NA;,
Issue 1223,
2000,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
5. |
...and reduce orthopaedic surgical pain |
|
Inpharma Weekly,
Volume &NA;,
Issue 1223,
2000,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
6. |
Acute myeloid leukaemia - new drug gets a bull's-eye view |
|
Inpharma Weekly,
Volume &NA;,
Issue 1223,
2000,
Page 7-8
Carmen Innes,
Preview
|
|
摘要:
Promising results have emerged from a phase II study using 'antibody-targeted chemotherapy' to treat acute myeloid leukaemia (AML). In the study, 34% of patients achieved remission when treated with CMA 676 (a humanised anti-CD33 antibody linked to the cytotoxic agent calicheamicin), a remission rate comparable to that achieved by standard combination chemotherapy regimens, according to researchers. The data, presented at the 41st Annual Meeting of the American Society of Hematology [New Orleans, US; December 1999], also indicate that the drug has other important advantages over standard chemotherapy, including a lack of significant mucositis or gastrointestinal (GI) toxicity, and the ability to be administered on an outpatient basis. The researchers also commented that while most chemotherapy regimens involve multiple drugs, CMA 676 is administered alone.
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
7. |
Morphine-6-glucuronide shows analgesic effects |
|
Inpharma Weekly,
Volume &NA;,
Issue 1223,
2000,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
8. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1223,
2000,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
9. |
Current drug developments brewing in epilepsy |
|
Inpharma Weekly,
Volume &NA;,
Issue 1223,
2000,
Page 10-11
Carmen Innes,
Ngaire Polwart,
Preview
|
|
摘要:
Over the past 2 decades there has been an upsurge in the availability of pharmacological agents for the treatment of epilepsy. Despite this, there is still no fully effective anticonvulsant agent. At the 53rd Annual Meeting of the American Epilepsy Society [Orlando, US; December 1999] there were a number of sessions dedicated to compounds that are currently being developed for various types of seizures.
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
10. |
Clopidogrel an alternative to ticlopidine in coronary stenting |
|
Inpharma Weekly,
Volume &NA;,
Issue 1223,
2000,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|